Author(s): Deslauriers F; Hoq M; Kaufman J; Enticott J; Lavoie KL; Bacon SL; Boyle JA; Danchin M;

Background: Despite COVID-19 infection being less severe in children compared to adults, vaccination for children from the age of 6 months onwards is recommended in many countries to reduce symptom severity and prevent severe disease. However, vaccination against COVID-19 for children remains controversial and uptake has been low. Aims: To assess and com ...

Article GUID: 38880694

Author(s): Zarei Ghobadi M; Teymoori-Rad M; Selvaraj G; Wei DQ;

No abstract available

Article GUID: 37475870

Author(s): Cénat JM; Moshirian Farahi SMM; Bakombo SM; Dalexis RD; Pongou R; Caulley L; Yaya S; Etowa J; Venkatesh V;

The COVID-19 pandemic disproportionately affected Black communities in Canada in terms of infection and mortality rates compared to the general population. Despite these facts, Black communities are among those with the highest level of COVID-19 vaccine mistrust (COVID-19 VM). We collected novel ...

Article GUID: 37185858

Author(s): Jin Y; Fayyaz A; Liaqat A; Khan A; Alshammari A; Wang Y; Gu RX; Wei DQ;

Monkeypox Virus (MPXV) is a growing public health threat with increasing cases and fatalities globally. To date, no specific vaccine or small molecule therapeutic choices are available for the treatment of MPXV disease. In this work, we employed proteomics and structural vaccinology approaches to design mRNA and multi-epitopes-based vaccines (MVC) against ...

Article GUID: 37116237

Author(s): Léger C; Deslauriers F; Gosselin Boucher V; Phillips M; Bacon SL; Lavoie KL;

Studies have shown that the protection afforded by COVID-19 vaccines against hospitalization and death decreases slowly over time due to the emergence of new variants and waning immunity. Accordingly, booster doses remain critical to minimizing the health impacts of the pandemic. This study examined the prevalence rate, sociodemographic determinants, and ...

Article GUID: 36851169

Author(s): Cénat JM; Noorishad PG; Bakombo SM; Onesi O; Mesbahi A; Darius WP; Caulley L; Yaya S; Chomienne MH; Etowa J; Venkatesh V; Dalexis RD; Pongou R; Labelle PR;

Black communities have been disproportionately impacted by Coronavirus Disease 2019 (COVID-19) in Canada, in terms of both number of infections and mortality rates. Yet, according to early studies, vaccine hesitancy appears to be higher in Black communities. The purpose of this systematic review ...

Article GUID: 36423032

Author(s): Vallis M; Bacon S; Corace K; Joyal-Desmarais K; Sheinfeld Gorin S; Paduano S; Presseau J; Rash J; Mengistu Yohannes A; Lavoie K;

Governments, public health officials and pharmaceutical companies have all mobilized resources to address the COVID-19 pandemic. Lockdowns, social distancing, and personal protective behaviours have been helpful but have shut down economies and disrupted normal activities. Vaccinations protect po ...

Article GUID: 35062668

Author(s): Azarpanah H; Farhadloo M; Vahidov R; Pilote L;

Background: Vaccine hesitancy has been a growing challenge for public health in recent decades. Among factors contributing to vaccine hesitancy, concerns regarding vaccine safety and Adverse Events (AEs) play the leading role. Moreover, cognitive biases are critical in connecting such concerns to vaccine hesitancy behaviors, but their role has not been co ...

Article GUID: 34530804

Author(s): Perveen S; Akram M; Nasar A; Arshad-Ayaz A; Naseem A;

This study explores the mechanism for timely and equitable distribution of coronavirus disease 2019 (COVID-19) vaccination among the various communities in Pakistan. It examines the factors that support and/or impede peoples' access and response towards COVID-19 vaccination in Pakistan. The study uses a literature synthesis approach to examine and ana ...

Article GUID: 34217150

Author(s): Stojanovic J; Boucher VG; Gagne M; Gupta S; Joyal-Desmarais K; Paduano S; Aburub AS; Sheinfeld Gorin SN; Kassianos AP; Ribeiro PAB; Bacon SL; Lavoie KL;

The success of large-scale COVID-19 vaccination campaigns is contingent upon people being willing to receive the vaccine. Our study explored COVID-19 vaccine hesitancy and its correlates in eight different countries around the globe. We analyzed convenience sample data collected between March 202 ...

Article GUID: 34204379

Author(s): Selvaraj G; Kaliamurthi S; Peslherbe GH; Wei DQ;

The Food and Drug Administration (FDA) has recently authorized the two messenger RNA (mRNA) vaccines BNT162b2 and mRNA-1273 for emergency use against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the COVID-19 coronavirus disease. BNT162b2 and mRNA-1273 vaccines were developed by Pfizer-BioNTech and Moderna, respectively, in 2020 ...

Article GUID: 34021862